Press Release: Zora Announces CERT – A Validated Test for Cardiovascular and Diabetes Risk Prediction
Espoo, Finland, 3 January 2018 – Zora Biosciences Oy (“Zora”) announces the expansion of its Coronary Event Risk Test (CERT) to include prediction of type…
Read moreZora and ceramides in Science Daily
New blood test developed by Zora Biosciences was featured in Science Daily News on March 10, 2017. The test predicst cardiovascular events in patients with…
Read more